semaj83/ctmatch_classification huggingface dataset:
Patient description: The patient is a 15 year old girl with the history of recurrent bilateral headache. The attacks come 2 times or more per week and each episode lasts around a day or a half. The pain is pulsating in quality and severe in intensity, causing trouble in her routine physical activity. The attacks are associated with nausea and photophobia. She recently noticed that that there are more attacks around her menstrual period. She is diagnosed with the migraine headache and is under treatment. She is a high-school student and living with her both parents. She is a book worm and spend her free time in a public library near her home. She is also interested in writing stories and has several short stories in English. She rarely does exercise. Her BMI is 21 with the BP of 100/60. There is nothing remarkable in her physical exam.

Clinical trial eligibility criteria: eligible ages (years): 12.0-18.0,  Substance Related Disorders 18 year old patients coming for well care or follow-up visits to one of the study sites, All levels of substance use, Able to read and understand English  Will not be available for 12 month follow-up period, Medically unstable at the time of the visit
Patient description: The patient is a 15 year old girl with the history of recurrent bilateral headache. The attacks come 2 times or more per week and each episode lasts around a day or a half. The pain is pulsating in quality and severe in intensity, causing trouble in her routine physical activity. The attacks are associated with nausea and photophobia. She recently noticed that that there are more attacks around her menstrual period. She is diagnosed with the migraine headache and is under treatment. She is a high-school student and living with her both parents. She is a book worm and spend her free time in a public library near her home. She is also interested in writing stories and has several short stories in English. She rarely does exercise. Her BMI is 21 with the BP of 100/60. There is nothing remarkable in her physical exam.

Clinical trial eligibility criteria: eligible ages (years): 12.0-65.0,  Migraine Common Migraine Classic Migraine Headache Medical history consistent with migraine with or without aura according to the International Headache Society (IHS) for at least 6 months prior to the study Between 3 to 12 migraine periods and no greater than 15 headache days (migraine and non-migraine) per month during the Baseline Phase No clinically significant abnormalities on neurological exams, electrocardiogram (ECG) or clinical laboratory test results at baseline Female patients must be postmenopausal for at least 1 year, surgically incapable of childbearing, practicing abstinence, or practicing an acceptable method of contraception (requires negative pregnancy test)  Patients with headaches other than migraine Patients with episodic tension or sinus headaches Onset of migraine after age of 50 years Patients who have failed more than two adequate regimens for migraine prophylaxis Patients who overuse pain medications or certain other medications
Patient description: The patient is a 15 year old girl with the history of recurrent bilateral headache. The attacks come 2 times or more per week and each episode lasts around a day or a half. The pain is pulsating in quality and severe in intensity, causing trouble in her routine physical activity. The attacks are associated with nausea and photophobia. She recently noticed that that there are more attacks around her menstrual period. She is diagnosed with the migraine headache and is under treatment. She is a high-school student and living with her both parents. She is a book worm and spend her free time in a public library near her home. She is also interested in writing stories and has several short stories in English. She rarely does exercise. Her BMI is 21 with the BP of 100/60. There is nothing remarkable in her physical exam.

Clinical trial eligibility criteria: eligible ages (years): 12.0-65.0,  Migraine Common Migraine Classic Migraine Headache Medical history consistent with migraine with or without aura according to the International Headache Society (IHS) for at least 1 year prior to the study Between 3 to 12 migraine periods and no greater than 15 headache days (migraine and non-migraine) per month during the Baseline Phase No clinically significant abnormalities on neurological exams, electrocardiogram (ECG) or clinical laboratory test results at baseline Female patients must be postmenopausal for at least 1 year, surgically incapable of childbearing, practicing abstinence, or practicing an acceptable method of contraception (requires negative pregnancy test)  Patients with headaches other than migraine Patients with episodic tension or sinus headaches Onset of migraine after age of 50 years Patients who have failed more than two adequate regimens for migraine prophylaxis Patients who overuse pain medications or certain other medications
Patient description: The patient is a 15 year old girl with the history of recurrent bilateral headache. The attacks come 2 times or more per week and each episode lasts around a day or a half. The pain is pulsating in quality and severe in intensity, causing trouble in her routine physical activity. The attacks are associated with nausea and photophobia. She recently noticed that that there are more attacks around her menstrual period. She is diagnosed with the migraine headache and is under treatment. She is a high-school student and living with her both parents. She is a book worm and spend her free time in a public library near her home. She is also interested in writing stories and has several short stories in English. She rarely does exercise. Her BMI is 21 with the BP of 100/60. There is nothing remarkable in her physical exam.

Clinical trial eligibility criteria: eligible ages (years): 6.0-15.0,  Migraine Children who have had several attacks of headaches that meet the International Headache Society Classification of pediatric migraine with or without aura (for example, headache lasts up to 48 hours, has a throbbing quality, is accompanied by nausea or sensitivity to light, is made worse by physical activity) Average of 3 to 10 migraine days per month for previous 3 months Weighs more than 20 kilograms (44 pounds) Able to swallow a tablet whole (without crushing it)  Took topiramate previously to prevent migraines but it was not effective Had to stop taking topiramate because of side effects Presence of cluster headaches, migraine aura without headache Had taken any medications for migraine prevention within 2 weeks before study start Presence of active liver disease or abnormal kidney function
Patient description: The patient is a 15 year old girl with the history of recurrent bilateral headache. The attacks come 2 times or more per week and each episode lasts around a day or a half. The pain is pulsating in quality and severe in intensity, causing trouble in her routine physical activity. The attacks are associated with nausea and photophobia. She recently noticed that that there are more attacks around her menstrual period. She is diagnosed with the migraine headache and is under treatment. She is a high-school student and living with her both parents. She is a book worm and spend her free time in a public library near her home. She is also interested in writing stories and has several short stories in English. She rarely does exercise. Her BMI is 21 with the BP of 100/60. There is nothing remarkable in her physical exam.

Clinical trial eligibility criteria: eligible ages (years): 18.0-999.0,  Osteoarthritis, Knee Rheumatoid Arthritis yrs. or older ACR for KOA or RA Able to speak and read English Able to ambulate at least household distances  Planned total joint replacement surgery in the next 2 years Contraindication to physical activity due to co-morbid condition Unable to perform basic self-care (functional class IV) or walk household distances Planned Relocation away from Chicago area in next two years
Patient description: The patient is a 15 year old girl with the history of recurrent bilateral headache. The attacks come 2 times or more per week and each episode lasts around a day or a half. The pain is pulsating in quality and severe in intensity, causing trouble in her routine physical activity. The attacks are associated with nausea and photophobia. She recently noticed that that there are more attacks around her menstrual period. She is diagnosed with the migraine headache and is under treatment. She is a high-school student and living with her both parents. She is a book worm and spend her free time in a public library near her home. She is also interested in writing stories and has several short stories in English. She rarely does exercise. Her BMI is 21 with the BP of 100/60. There is nothing remarkable in her physical exam.

Clinical trial eligibility criteria: eligible ages (years): 12.0-17.0,  Migraine Have a history of migraine for at least one year Have an average of 1 migraines per month for the 6 months prior to study entry Able to swallow oral medication Able to complete a headache diary Only taking one migraine preventive medication and on the same dose of that medication for at least 30 days before entering the study)  Have an allergy to almotriptan malate or have stopped taking almotriptan malate due to side effects Have 15 or more days within a month in which you have a headache Usually experience migraine aura (most common symptoms being visual disturbances or tingling sensations before migraine pain begins) without a headache Experience more than 6 non-migraine headaches per month
Patient description: The patient is a 15 year old girl with the history of recurrent bilateral headache. The attacks come 2 times or more per week and each episode lasts around a day or a half. The pain is pulsating in quality and severe in intensity, causing trouble in her routine physical activity. The attacks are associated with nausea and photophobia. She recently noticed that that there are more attacks around her menstrual period. She is diagnosed with the migraine headache and is under treatment. She is a high-school student and living with her both parents. She is a book worm and spend her free time in a public library near her home. She is also interested in writing stories and has several short stories in English. She rarely does exercise. Her BMI is 21 with the BP of 100/60. There is nothing remarkable in her physical exam.

Clinical trial eligibility criteria: eligible ages (years): 0.0-999.0,  Familial Hemiplegic Migraine Type 1 and 2 Healthy Volunteers Patients: Diagnosis of familial hemiplegic migraine (IHS-classification criteria) caused by mutations in the CACNA1A gene and the ATP1A2 gene. Controls: healthy volunteers  Controls: No primary headache in their own history Patients and controls A history of cerebrovascular disease and other CNS disease A history of serious somatic and mental disease A history suggesting ischaemic heart disease A history of hypo or hypertension Daily intake of medication apart from oral contraceptives Abuse of alcohol or medicine (opioid analgesics) Pregnant or breastfeeding women. On the study day
Patient description: The patient is a 15 year old girl with the history of recurrent bilateral headache. The attacks come 2 times or more per week and each episode lasts around a day or a half. The pain is pulsating in quality and severe in intensity, causing trouble in her routine physical activity. The attacks are associated with nausea and photophobia. She recently noticed that that there are more attacks around her menstrual period. She is diagnosed with the migraine headache and is under treatment. She is a high-school student and living with her both parents. She is a book worm and spend her free time in a public library near her home. She is also interested in writing stories and has several short stories in English. She rarely does exercise. Her BMI is 21 with the BP of 100/60. There is nothing remarkable in her physical exam.

Clinical trial eligibility criteria: eligible ages (years): 10.0-999.0,  Hereditary Angioedema (HAE) Age 10 and older Documented diagnosis of HAE, Type I or II Executed informed consent Presentation for treatment within 8 hours of patient recognition of moderate to severe HAE attack  Receipt of investigational drug or device, other than DX-88, within 30 days of treatment Receipt of non-investigational C1-INH (C1 esterase inhibitor) within 7 days of treatment Diagnostic of acquired angioedema, estrogen-dependent angioedema or drug induced angioedema Pregnancy or breastfeeding Patients who have received DX-88 within 7 days of presentation for dosing in the Double-blind Phase
Patient description: The patient is a 15 year old girl with the history of recurrent bilateral headache. The attacks come 2 times or more per week and each episode lasts around a day or a half. The pain is pulsating in quality and severe in intensity, causing trouble in her routine physical activity. The attacks are associated with nausea and photophobia. She recently noticed that that there are more attacks around her menstrual period. She is diagnosed with the migraine headache and is under treatment. She is a high-school student and living with her both parents. She is a book worm and spend her free time in a public library near her home. She is also interested in writing stories and has several short stories in English. She rarely does exercise. Her BMI is 21 with the BP of 100/60. There is nothing remarkable in her physical exam.

Clinical trial eligibility criteria: eligible ages (years): 9.0-12.0,  Pediatric Recurrent Headache & Abdominal Pain child 9 to 16 years of age child had recurrent headache and abdominal pain at least 3 times a month child's physical examination normal access to a telephone in the home speak and write english mild to moderate anxiety symptomology  child's pain due to trauma, systemic disease or disorder child received any psychological treatment for this or similar disorder in the past 6 months
Patient description: The patient is a 15 year old girl with the history of recurrent bilateral headache. The attacks come 2 times or more per week and each episode lasts around a day or a half. The pain is pulsating in quality and severe in intensity, causing trouble in her routine physical activity. The attacks are associated with nausea and photophobia. She recently noticed that that there are more attacks around her menstrual period. She is diagnosed with the migraine headache and is under treatment. She is a high-school student and living with her both parents. She is a book worm and spend her free time in a public library near her home. She is also interested in writing stories and has several short stories in English. She rarely does exercise. Her BMI is 21 with the BP of 100/60. There is nothing remarkable in her physical exam.

Clinical trial eligibility criteria: eligible ages (years): 6.0-999.0,  Cystic Fibrosis Confirmed diagnosis of CF (sweat tests/genotype) The subject, or their legal guardian for children under 18 years old, must provide written informed consent The subject must be in stable clinical condition at the time of and for a period of 14 days prior to their recruitment into the study Age > 6 years old FEV1 > 40% predicted for height, age and gender Proven or anticipated compliance with therapy or study protocol Regular attendee at a Cystic Fibrosis Clinic (> 2 visits per year) Able to reproducibly perform lung function tests (spirometry) Relatively stable nutritional status (< 2 kg weight loss in last 6 months and < 5 kg weight loss in last year) Known to have "normal" (for CF subject) laboratory tests  Requiring home oxygen (pO2 <55mmHg or pCO2 >50mmHg) or assisted ventilation Considered "terminally ill" or listed for transplantation (either lung or liver). Subjects that are listed for transplant after being enrolled in the trial are eligible to continue in the trial Subjects colonised with Burkholderia cepacia. However, if a subject becomes colonised with B. cepacia during the trial, they should continue in the trial. Subjects should be considered to be B. cepacia positive if they have had even a single lifetime isolate. In these subjects, spirometry should be measured on a dedicated spirometer Cigarette smoker Exposure to investigational drugs within the past 30 days Major haemoptysis (> 60 mL in a single episode) within the last twelve months Concurrent illnesses eg. cor pulmonale, clinically significant liver disease (portal hypertension, varices) Known allergy to quinine sulphate, Glucose 6-phosphate dehydrogenase deficiency Immune thrombocytopaenic purpura Pregnant or lactating females
Patient description: The patient is a 15 year old girl with the history of recurrent bilateral headache. The attacks come 2 times or more per week and each episode lasts around a day or a half. The pain is pulsating in quality and severe in intensity, causing trouble in her routine physical activity. The attacks are associated with nausea and photophobia. She recently noticed that that there are more attacks around her menstrual period. She is diagnosed with the migraine headache and is under treatment. She is a high-school student and living with her both parents. She is a book worm and spend her free time in a public library near her home. She is also interested in writing stories and has several short stories in English. She rarely does exercise. Her BMI is 21 with the BP of 100/60. There is nothing remarkable in her physical exam.

Clinical trial eligibility criteria: eligible ages (years): 12.0-32.0,  Cystic Fibrosis Related Diabetes Cystic fibrosis patients aged 12-32 years Impaired glucose tolerance or CFRD defined as fasting blood glucose (FBG) and post-prandial blood glucose (pp) equal to: FBG <126 and pp 151-200, or FBG <126 and pp >200, or FBG >126 and pp >200 Type 1 diabetes control patients aged 12-32 years  Colonization with Burkholderia cepacia currently on corticosteroid medication pregnant medically unstable Unable to understand the insulin pump directions
Patient description: The patient is a 15 year old girl with the history of recurrent bilateral headache. The attacks come 2 times or more per week and each episode lasts around a day or a half. The pain is pulsating in quality and severe in intensity, causing trouble in her routine physical activity. The attacks are associated with nausea and photophobia. She recently noticed that that there are more attacks around her menstrual period. She is diagnosed with the migraine headache and is under treatment. She is a high-school student and living with her both parents. She is a book worm and spend her free time in a public library near her home. She is also interested in writing stories and has several short stories in English. She rarely does exercise. Her BMI is 21 with the BP of 100/60. There is nothing remarkable in her physical exam.

Clinical trial eligibility criteria: eligible ages (years): 0.0-999.0,  Birth Defects Pregnancy Complications Multiple Sclerosis The subjects must meet the following for registration Enroll prospectively (patient is still pregnant and no structural defects have been noted on a prenatal test) Diagnosed with MS prior to or during the current pregnancy Exposed to Betaseron® on or after the first day of the patient's last menstrual period Provide verbal consent to participate in the Registry Verbally provide contact information for herself, her HCP, and the infant's HCP (as applicable)
Patient description: The patient is a 15 year old girl with the history of recurrent bilateral headache. The attacks come 2 times or more per week and each episode lasts around a day or a half. The pain is pulsating in quality and severe in intensity, causing trouble in her routine physical activity. The attacks are associated with nausea and photophobia. She recently noticed that that there are more attacks around her menstrual period. She is diagnosed with the migraine headache and is under treatment. She is a high-school student and living with her both parents. She is a book worm and spend her free time in a public library near her home. She is also interested in writing stories and has several short stories in English. She rarely does exercise. Her BMI is 21 with the BP of 100/60. There is nothing remarkable in her physical exam.

Clinical trial eligibility criteria: eligible ages (years): 18.0-65.0,  Migraine Disorders Migraine Suffering from migraine with or without aura Migraine for at least one year, and the age of onset was prior to 50 years Consistent migraine headache over time and has had at least 1 migraine headache attacks but less than 15 days with headache (migraine or non-migraine) per month in each of the three months prior to the Screening Visit and maintains this requirement during the baseline period Able to distinguish migraine headache attacks as discreet attacks from other headaches (i.e. tension-type headaches) Typically have moderate to severe migraine pain preceded by an identifiable mild pain phase No clinically significant abnormality identified on the medical or laboratory evaluation. A subject with a clinical abnormality or laboratory parameters outside the reference range may be included only if the doctor considers that the finding will not introduce additional risk factors and will not interfere with the study procedures Written informed consent prior to entry into the study Females who are: a) non-childbearing potential or, b) of child-bearing potential, has a negative pregnancy test at screen, and is taken adequate contraceptive measures  As a result of the medical interview, physical examination or screening investigations, that the doctor considers the subject unfit for the study History of alcohol, substance or drug abuse within the last year Taken a migraine prophylactic medication within 1 month of the Screening Visit Uses an opiate as first line acute treatment for migraine attacks History of ergotamine, triptan, opioid, or combination medication intake on greater than/equal 10 days per month on a regular basis for greater than/equal 3 months History of simple analgesic intake on greater than/equal 15 days per month for greater than/equal 3 months Do not receive migraine relief from a triptan migraine treatment Uncontrolled hypertension at the Screening Visit, defined as systolic blood pressure >140mmHg or diastolic blood pressure >90mmHg Evidence of renal impairment calculated creatinine clearance <60ml/min or clinically relevant finding on urinalysis